PYC 8.11% 17.0¢ pyc therapeutics limited

Ann: Corporate Presentation - May 2022, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 932 Posts.
    lightbulb Created with Sketch. 177
    “Delivery” remains the foundation of success, praying that PYC has pioneered a platform that will help us leapfrog into success:

    quote from the article that I found relevant to PYC current state:

    “…Without a doubt, conquering delivery was foundational to building Alnylam. It was the key technology hurdle to turning Nobel-prize-winning science into medicine.

    There was never a ‘straight line’ to a solution—there rarely is in either science or business.

    Ultimately, the key was to persevere, follow the science and foster an environment of innovation. The ultimate solutions relied on fundamental advances in both novel delivery methods andnovel chemistry applied to the siRNA itself.

    It was also critical to be bold and take risks, bringing prototypes into early clinical studies and learning (safely, of course) how to optimize based on findings in man.

    Finally, Delivery (capital ‘D’) has never been ‘over’ for us. We have continued (and continue) to optimize the technology to bring our best innovations to patients...”
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.